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Musculoskeletal aging is detrimental to multiple bodily functions and starts early, probably
in the fourth decade of an individual’s life. Sarcopenia is a health problem that is
expected to only increase as a greater portion of the population lives longer; prevalence
of the related musculoskeletal diseases is similarly expected to increase. Unraveling
the biological and biomechanical associations and molecular mechanisms underlying
these diseases represents a formidable challenge. There are two major problems
making disentangling the biological complexity of musculoskeletal aging difficult: (a) it
is a systemic, rather than “compartmental,” problem, which should be approached
accordingly, and (b) the aging per se is neither well defined nor reliably measurable.
A unique challenge of studying any age-related condition is a need of distinguishing
between the “norm” and “pathology,” which are interwoven throughout the aging
organism. We argue that detecting genes with pleiotropic functions in musculoskeletal
aging is needed to provide insights into the potential biological mechanisms underlying
inter-individual differences insusceptibility to the musculoskeletal diseases. However,
exploring pleiotropic relationships among the system’s components is challenging both
methodologically and conceptually. We aimed to focus on genetic aspects of the cross-talk
between muscle and its “neighboring” tissues and organs (tendon, bone, and cartilage),
and to explore the role of genetics to find the new molecular links between skeletal
muscle and other parts of the “musculoskeleton.” Identification of significant genetic
variants underlying the musculoskeletal system’s aging is now possible more than ever
due to the currently available advanced genomic technologies. In summary, a “holistic”
genetic approach is needed to study the systems’s normal functioning and the disease
predisposition in order to improve musculoskeletal health.
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Aging of the musculoskeletal system starts early and is detrimen-
tal to multiple functions of the whole organism, since it leads
to disability and degenerative diseases. The age-related muscu-
loskeletal changes are important in medical risk assessment and
care because they influence the responses to treatment and out-
comes of therapy. Challenges posed by this growing problem of
health care and social medicine are well recognized and are a
focus of efforts bymany health professionals, as well as biomedical
scientists.
There are two major problems that one faces while trying
to disentangle the biological complexity of the musculoskeletal
aging: (a) it is a systemic, rather than “compartmental,” problem,
which should be dealt with accordingly, (b) the aging per se is
neither well defined nor reliably measurable. A unique challenge
of studying any age-related process is a need of distinguishing
between the “norm” and “pathology,” which are interwoven in
the aging. When another dimension is added, namely genetics
underlying the system’s functioning, even less is known about this
aspect, and attempts to decipher genetic relationships between
the system’s components are few. By definition, genetic study of
a complex system should explore pleiotropic relationships among
the system’s parts; however, this is challenging both methodolog-
ically and conceptually.
To disentangle the aging-related pathology from the home-
ostasis particular for aging steady-state, is a challenging task.
Despite the multiple definitions of the aging process were pro-
posed, there is no single agreed upon and reliable measurement
(Karasik, 2011), therefore underlying molecular mechanism of
aging is still not fully understood (de Magalhaes et al., 2009).
The definition of aging is complicated by the occurrence of var-
ious diseases that modify body functions and tissue structures;
these disease-related changes that are common in older persons
are often hard to delineate from the aging process per se (Nair,
2005). Disease processes and environmental factors also need to
be taken into consideration since they affect the rate of aging.
Therefore, for our purpose, the “aging” will be considered as
a changing environment in which the musculoskeletal system’s
homeostasis takes place. Aging-related factors provide an addi-
tional challenge for the study of genetic effects, since parameters
such as co-expression of genes and penetrance of genetic variants
can be “masked” by aging. It is necessary to detect genes with
pleiotropic functions which are involved in the aging process,
since this can provide insights into the potential biological mech-
anisms underlying inter-individual differences in susceptibility to
the aging (Karasik, 2011). In turn, the disentangling effects of
these genes in some of the facets of the musculoskeletal system
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might contribute to the knowledge related to the aging process of
the entire organism.
Identification of genetic variants associated with traits related
to the musculoskeletal system’s physiology is now possible, due
to the rapid development of various novel sequencing technolo-
gies, each aspiring to reduce costs to the point at which the
genomes of individual humans could be sequenced as part of
routine health care (Shendure et al., 2004), as well as the possi-
bility to replicate associations in large human cohorts. Although
many recent reviews have been dedicated to aging changes in
the musculoskeletal system, most focused on the contribution of
advanced age to one of the components of the system and/or
on development of one of the musculoskeletal diseases—e.g.,
osteoporosis (Khosla et al., 2011), osteoarthritis (Loeser, 2010),
sarcopenia (Rolland et al., 2008; Fielding et al., 2011), tendini-
tis (Rechardt et al., 2010) and similar. In turn, this perspective
will focus mostly on the muscular part; although we do not
attempt to assign the muscle a central role in the “musculoskele-
tal” system, it seems that the biological importance of the muscle
is frequently overlooked while studying other components, and
undeservedly so.
PARTS OF THE MUSCULOSKELETON IN ADULTHOOD
AND AGING
The term “musculoskeletal system” is most frequently used to
describe the biomechanical relationships between muscle, ten-
don, fascia, bone, and cartilage, which are most evident in
locomotion or mastication. However, these organs are intercon-
nected at many other levels, including biochemically and micro-
structurally. Musculoskeleton includes muscle, tendon, fascia,
bone, and cartilage. Skeletal (striated) muscle is a tissue on its
own, while other components of the musculoskeleton belong
to the connective tissue and have different embryonic origin.
Tendon, ligament, bone, and cartilage are connective tissues of
mesenchymal origin. Morpho-functional components of the sys-
tem also include fascia and aponeuroses, which are beyond the
scope of the present review. It is important to note that many
components of the skeletal muscle are also built by connective
tissue. Muscle extracellular matrix (ECM) is often subdivided
into epimysium (around the whole muscle), perimysium (around
groups of muscle cells), and endomysium (around the muscle
cell), and the basement membrane which is considered to be
distinct from the endomysium. However, this simplified presen-
tation does not fully explain the transmission of force from the
myofiber to the tendon. Detailed studies of the transition zones
between endomysium, perimysium, epimysium, and tendon are
lacking.(Gillies and Lieber, 2011).
Muscle fibers are multinucleated, post-mitotic, highly differ-
entiated cell agglomerates. Muscles of different functions are
probably physiologically distinct; some are chronically active,
perform antigravity functions, operate at long lengths, or are
involved in rapid movements (Gillies and Lieber, 2011). Based
on contractile and metabolic properties, muscle fibers are com-
monly classified as slow-twitch and fast-twitch, which are further
subdivided to more aerobic (Type I) and the more anaerobic gly-
colytic (Type II), fibers. Adult fast/type-II fibers express one or
more of the six type II sarcomeric myosin heavy chain (MHC)
genes, while slow/type I fibers express β-MHC isoform (Resnicow
et al., 2010). There are different types of collagen expressed dur-
ing skeletal muscle development, although fibrillar types I and III
predominate in adult endo-, peri-, and epimysium (Gillies and
Lieber, 2011).
Under normal conditions, skeletal muscle is relatively quies-
cent, however, it harbors considerable regenerative capacity due
to the presence of tissue-resident muscle stem cells known as the
satellite cells (Sacco et al., 2010). However, with aging, cellular
changes occur that reflect a reduced regenerative capacity of mus-
cle (Collier et al., 2011). Common conditions of muscle aging
include sarcopenia (muscle wasting), myosteatosis (gradual infil-
tration of muscle with fatty tissue), and fibrosis (accumulation of
excess ECM). Morphologically, with advanced age, there are alter-
ations in muscle morphology: the muscle tissue is progressively
replaced by adipose and fibrotic tissue. Muscle mass is well main-
tained through the fourth decade of life (Nair, 2005) and shows
a moderate decline between 50 and 60 years of age, followed by a
more accelerated rate of loss beyond 60 years of age (Deschenes,
2004). Sarcopenia is manifested by decreases in muscle strength
and muscle mass with age. The age-specific response to damage
seen in muscles of older people includes higher protein expres-
sion for nuclear factor kappa B (Nf-κB) and heat shock protein
70 (Mann et al., 2011). Senescence is associated with a decrement
in the number of muscle fibers along with a reduction in the size
of type II, but not type I fibers (Deschenes, 2004); the relative
percentages of different fiber types appear to be unaffected by age
(Deschenes, 2004).
Sarcopenia seems to occur by mechanisms that partly are
unique to it and partly are common to other forms of atro-
phy (Mann et al., 2011). There are several potential causes of
sarcopenia, among which the most prominent are age-related
changes in the hormonal status, low levels of physical activity,
reduced protein intake, and increased oxidative stress (Poehlman
et al., 1995). Physiologically, after acute injury, such as after sports
injuries, damaged or dead fibers are first removed by inflamma-
tory cells, and they are then repaired or replaced by satellite cells
(Cosgrove et al., 2009; Mann et al., 2011), which play a major role
in post-natal muscle growth and repair. Successful regeneration
of healthy muscle thus requires an inflammatory response with
the migration and proliferation of fibroblasts, in order to pro-
duce new temporary ECM components, such as collagen types I
and III, fibronectin, and others. The primary mononuclear cell
in normal muscle ECM is the fibroblast, which is responsible
for producing the majority of ECM components, including col-
lagen, fibronectin, and proteoglycan (Gillies and Lieber, 2011).
Fibroblasts are able to convert mechanical signals into altered
gene expression [see review by Gillies and Lieber (2011)]. When
tissue is damaged, fibroblasts migrate into the damaged area and
begin to produce and remodel the ECM in response to pro-
fibrotic cytokines such as transforming growth factor-β (Mann
et al., 2011). They serve to stabilize the tissue and act as a scaf-
fold to which the new fibers can migrate, which is necessary for
effective repair of damaged tissues.
However, with advanced aging, the chronic inflammatory
response drives unrestrained wound healing and tissue fibro-
sis, characterized by excessive and persistent fibrin/fibrinogen
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deposition (Mann et al., 2011). Alternatively-activated macro-
phages have been shown to promote fibrosis in several differ-
ent pathogenic conditions (Wynn, 2008). Satellite cells can also
differentiate into fibroblasts (Brack et al., 2007).
Fibrin(ogen) can also directly stimulate the expression of colla-
gen; in turn, collagen type I can markedly suppress differentiation
of C2C12 cells (the cell line established to become muscle), thus
muscle fibrosis is seen as a self-perpetuating mechanism of colla-
gen overproduction (Mann et al., 2011). One might hypothesize
that, similar to sarcopenia, advanced muscle fibrosis will have a
detrimental effect also on bones, both due to diminished muscle
strain and a lack of the myokines due to insufficient population
of the myocytes.
With “normal” aging, there is a marked increase in the for-
mation of advanced glycation end-products (AGEs). AGEs are
produced by the spontaneous non-enzymatic glycation of pro-
teins (Grillo and Colombatto, 2008) and crosslinking. These
collagen modifications increase the stiffness of muscle connec-
tive tissue, thereby contributing to impaired muscle function in
the older person (Mann et al., 2011). AGEs do not only affect
muscles: the accumulation of AGEs in articular cartilage with
aging (independent of diabetes) may be attributed in large part
to the very slow turnover of cartilage matrix components (Lotz
and Loeser, 2012). It has been suggested that in bones, AGEs
enhance osteoclast-induced bone resorption, and AGE modifi-
cation of bone proteins disturbs bone remodeling (Hein et al.,
2006). Interestingly, it was shown that AGE-specific binding sites
are present in cultured osteoblast-like cells, thus AGEs can regu-
late proliferation and differentiation of osteoblastic lineage (Hein
et al., 2006).
In an alternative path to muscular degeneration with age,
intermuscular adipose tissue content and intramyocellular lipid
deposits increase, and adipose tissue appears to replacemuscle tis-
sue (Song et al., 2004). Muscle lipid content can be reliably mea-
sured as muscle attenuation with computed tomography (CT)
(Miljkovic et al., 2009). Intermuscular adipose tissue may accu-
mulate in skeletal muscle of elderly people as a result of satellite
cells differentiating into adipogenic cells. In aged muscle, there is
also an accumulation of the intramuscular, extracellular fat: these
fatty deposits are generally localized to the perimysium (Gillies
and Lieber, 2011) (more details on the intermuscular adipose
tissue are provided below).
TENDONS
Tendons are dense, fibrous connective tissue bands that connect
muscle to bone, transmitting the muscular forces to perform
movement. Fibroblasts aid in tendon development and main-
tenance (Gillies and Lieber, 2011). Tendons are built mostly of
collagen; however, expression of fibrillar collagens varies along
the bone insertion: tendon fibroblasts expressed type I collagen,
fibrochondrocytes in the transitional tissue between tendon and
bone expressed type II and X collagen, and osteoblasts in bone
again expressed type I collagen (Thomopoulos, 2011). The pro-
teoglycans found in tendons, including decorin, fibromodulin,
biglycan, and lumican, act to lubricate and organize collagen
fiber bundles (Ito et al., 2010). Tendon and perimysium both
contain primarily type I collagen, and the primary proteoglycan
for both structures is decorin. Perimysium seems to be contin-
uous with tendon (Gillies and Lieber, 2011): collagen in tendon
becomes much more organized than collagen in perimysium;
high tensile loads on the tendon may organize collagen fibers
to align with the muscle axis (Gillies and Lieber, 2011). With
aging, enzymatic and nonenzymatic cross-linking is observed.
Although cross-linking might signify an aberrant collagen, and
thus mechanically less stable tendon, some proposed this might
be amechanism to maintain the mechanical properties of the ten-
don into advanced age (Couppe et al., 2009). Generally, tendon
damage from overuse or degeneration is a common clinical prob-
lem in geriatrics and orthopedics, because damaged tendon heals
very slowly and rarely recovers completely (Ito et al., 2010).
BONE
Bones develop during embryonic period by either intramem-
branous ossification (flat bones) or endochondral ossification.
The majority of the bones develop endochondrally; those include
the long, short, and irregular bones, thus most of the bones are
developmentally related to cartilage. Bone cells include osteo-
clasts, osteoblasts, and osteocytes, whose simplified roles can
be described as bone resorption, bone formation, and sensor-
ing/mechanosensitivity, respectively. Bones are built by two com-
partments, cortical and cancellous (trabecular). Cortical bone
consists of a repeating unit, named osteon; the unit structure
of cancellous bone is a trabeculum (with a built-in “hemi-
osteon”). Muscle and tendon interconnect to transmit force to
bone, and the tendon inserts to the bone frequently via fibrocar-
tilage (enthesis) (Gillies and Lieber, 2011; Thomopoulos, 2011).
The fibrocartilaginous enthesis forms partly through endochon-
dral ossification (Thomopoulos, 2011). The decrease in collagen
fiber orientation in enthesis along with a functionally graded
insertion of tendon to bone are major determinants of ensuing
stiffness. The linear increase in mineral accumulation on colla-
gen fibers provides significant stiffening of the fibers, but only for
concentrations of mineral above a “percolation threshold” cor-
responding to formation of a mechanically continuous mineral
network (Thomopoulos, 2011).
Osteoporosis is among the most common skeletal disorders;
it is characterized by low bone mineral density (BMD) and an
increased risk of fragility fractures. BMD predictably declines
with advanced age; it is the best clinical predictor of future
osteoporotic fracture risk. However, BMD measures are rela-
tively ineffective in predicting the skeleton’s ability to withstand
the forces that produce fractures (Christiansen and Bouxsein,
2010). BMD is also a complex trait controlled by multiple envi-
ronmental and genetic determinants with individually modest
effects, which makes it a difficult phenotype to use in biological
exploration. Degenerative bone diseases have been described in
detail in a number of recent reviews (Michaelsson et al., 2007;
Shanmugarajan et al., 2007) and are therefore not discussed
further here.
JOINTS
Joints can be classified into three groups based upon how the
bones within the joint are connected: fibrous, cartilaginous, and
synovial (Benjamin et al., 1995). Joint tissues include articular
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cartilage, ligaments, and menisci, which are frequently sur-
rounded by synovial membrane and fluid. Articular cartilage
contains only post-mitotic cells of mesenchymal lineage; with
a very low rate of replication during adulthood, which makes
them vulnerable to trauma and most affected by the aging pro-
cess (Lotz and Loeser, 2012). The major collagens of the cartilage
are Type II (characteristic of chondrocytes) and Type X (char-
acteristic of hypertrophic chondrocytes) (Thomopoulos, 2011).
Cells of cartilage, chondrocytes, and osteoblasts are well inter-
related: notably, the chondrocytes frequently transdifferentiate
into osteoblasts. Cartilage thus has an innate ability to ossify.
Fibrous suture joints in the skull are eventually replaced by bone
in childhood. Cartilaginous joints are found in growth regions
of the long bones (Wu et al., 2011), where they are also grad-
ually replaced by bone during childhood. A highly prevalent
change in aging cartilage is cartilage calcification—by deposition
of calcium-containing crystals, mainly calcium pyrophosphate
and basic calcium phosphate due to increased pyrophosphate
production by chondrocytes from aged cartilage (Lotz and Loeser,
2012).
Notably, similar to cartilage, there is an increased incidence
of heterotopic ossification, a condition where bone forms within
muscles, with aging; it can cause muscle necrosis. The new bone
seems to actually form in connective tissue between muscle planes
and not in the muscle itself. Heterotopic bone formation occurs
also in ankylosing spondylitis, hypertrophic osteoarthrosis, and
diffuse idiopathic skeletal hyperostosis. A useful review on inher-
ited human diseases of heterotopic bone formation was recently
published (Shore and Kaplan, 2010). Degeneration of other joint
tissues, such as ligaments and menisci has been examined at some
level (Pauli et al., 2011), however at a lesser extent than the aging
of cartilage.
ETIOLOGY OF COMMONMUSCULOSKELETAL
AGE-RELATED CONDITIONS
The musculoskeletal system can be regulated by multiple biolog-
ical mechanisms, including anatomical (anabolic), physiological
(anaerobic threshold, hormones), or even behavioral (desire to
exercise, pain tolerance) pathways. To get a better understanding
of the system’s molecular organization and higher-level function,
novel pathways with pleiotropic effects of the musculoskeletal
system’s components should be discovered. Pleiotropy is usually
implied when a single gene seems to control multiple phenotypic
traits. Strictly speaking, this would be a “direct” pleiotropy; usu-
ally, there might be a mediation of a gene’s effect via one trait onto
the other, or even a confounding by some third factor.
Each compartment of the musculoskeletal system—muscle,
tendon, bone, and cartilage—undergoes aging. Despite years of
intense studies, we are still relatively ignorant of the molecular
basis of the majority of genetically-influenced musculoskeletal
phenotypes. In terms of genetics, each degenerative condition is
a common and complex disease; even some “rare” syndromes,
such as Duchenne Muscular Dystrophy (DMD) or rheumatoid
arthritis (RA), are also complexly-regulated traits. It can be antic-
ipated that with the broad use of next generation sequencing
(NGS), most causative genes for rare musculoskeletal diseases
will be identified in the next few years (Laing, 2012). “Rare”
diseases are thus expected to provide some insight into the genet-
ics of common diseases of the musculoskeletal aging, since they
share etiology with the latter [see, for example, LRP5 gene, origi-
nally discovered in the rare diseases such as high-bone-mass trait
and osteoporosis-pseudoglioma (Boyden et al., 2002; Little et al.,
2002) but further being associated with BMD and fracture risk
in the general population (Ferrari et al., 2005; Kiel et al., 2007;
Estrada et al., 2012)].
Degenerative musculoskeletal process (Lotz and Loeser, 2012)
seems to be a reflection of a general aging, which can be seen as
disorganization of the cellular homeostasis mechanisms. Survival
and normal function of post-mitotic cells like muscle fibers and
mature articular chondrocytes depends on their ability to cope
with persistent wear and tear. Conceptually, age-related patholo-
gies originate from limitations in the maintenance and repair
mechanisms of DNA, by e.g., anomalies in the antioxidant mech-
anisms that contribute to the detoxification of reactive oxygen
species (ROS) (Lotz and Loeser, 2012).
TELOMERES ANDMITOCHONDRIA IN MUSCULOSKELETAL AGING
Shortening of the telomeres and mitochondrial somatic muta-
tions were suggested to have an impact on aging skeletal muscle
[see recent studies by Dillon et al. (2012) and Payne et al. (2011)].
The shortening of the telomeres at the ends of chromosomes
is considered to be a measure of cell senescence; it has been
associated with age-related disease and mortality (Wheeler and
Kim, 2011). It was also shown that centenarians and their off-
spring maintain longer telomeres compared with controls and
that longer telomeres are associated with protection from age-
related diseases, better cognitive function, and lipid profiles of
healthy aging (Atzmon et al., 2010; Wheeler and Kim, 2011).
A recent study identified a common haplotype of hTERT, cod-
ing for the human telomerase reverse transcriptase gene, that
is enriched in centenarians and associated with longer telomere
length (Atzmon et al., 2010). Aging of mitotically active human
tissues with high turnover, including blood, liver, skin, testis, and
kidneys, is accompanied by telomere shortening (Aikata et al.,
2000). In contrast, analysis of telomeres in skeletal muscle during
aging reveals only a mild shortening (Decary et al., 1997; Renault
et al., 2002), presumably reflecting the low rate of proliferation of
myogenic progenitors and muscle tissue turnover during normal
aging (Sacco et al., 2010). Telomere length was shorter in women
with osteoporosis. In bones, telomere shortening and telomerase
activity have been linked to in vitro osteoblast senescence and to
increased secretion of pro-inflammatory cytokines (Valdes et al.,
2007). Telomere shortening can also be promoted by extrinsic
or “stress-induced” factors such as the chronic effects of oxida-
tive damage and inflammation (Loeser, 2010; Lotz and Loeser,
2012).
Mitochondrial dysfunction and excessive ROS production
contribute to oxidative stress and chronic inflammation of the
musculoskeleton. For example, ROS-mediated adverse effects
of diabetes are seen on bone formation and maintenance, as
ROS greatly influence the generation and survival of osteoclasts,
osteoblasts, and osteocytes (Manolagas, 2010). Excessive levels of
ROS can contribute to aging in many tissues (Ahima, 2009): in
muscles, ROS may trigger different signaling pathways leading to
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diverging responses, including either autophagy or apoptosis in
the tissues (Barbieri and Sestili, 2012). In joints, there is increased
apoptosis in OA chondrocytes following exposure to oxygen rad-
icals; also, oxidized low-density lipoprotein (LDL) could form
when LDL present in synovial fluid reacts with ROS (Lotz and
Loeser, 2012).
MOLECULAR CASCADES INVOLVED IN THE INFLAMMATION
A direct relationship exists between aging and increasing inci-
dence of chronic diseases, which is in part due to the underlying
chronic inflammatory state. However, the molecular mechanisms
underlying this chronic inflammatory condition, such as local
infiltration by inflammatory cells, are presently unclear, as well as
whether aging-related inflammation can be triggered by cellular
senescence.
The circulating concentrations of cytokines and C-reactive
protein are often elevated in people with age-related diseases,
including obesity and Type 2 diabetes, osteoporosis, RA, and
Alzheimer disease (Tan et al., 2007; Peake et al., 2010). Some
form of inflammatory response is necessary to repair dam-
aged tissues effectively; however, chronic inflammatory responses
drive unrestrained wound healing and fibrosis especially in aging
(Mann et al., 2011). Intermuscular adipose tissue may accumu-
late in skeletal muscle of elderly people as a result of satellite
cells differentiating into adipogenic cells. Satellite cells can also
differentiate into fibroblasts in “old” muscles (Le Grand and
Rudnicki, 2007). Both adipocytes and fibroblasts, which replace
myoblasts, produce proinflammatory cytokines, which in turn
may contribute to the inflammatory state of skeletal muscle in the
elderly.
Local inflammation in adipose and synovial tissues is a
causative factor in some of the degenerative changes in these
and neighboring tissues. Anti-inflammatory cytokines (e.g., IL-
4, IL-10, IL-13) play central role in resolving local inflammation
and repairing muscle tissue following injury (Peake et al., 2010).
It is unclear whether “overflow” of inflammatory cytokines and
reactive oxygen/nitrogen species from these tissues and their
“spill-over” into the circulation can cause inflammation in neigh-
boring tissues, such as bone. Systemic inflammation in elderly
people has been hypothesized for a long time to produce a back-
ground milieu (Finch and Ruvkun, 2001; Peake et al., 2010),
which affects even distant organs.
Paradoxical relationships between exercise, which triggers the
skeletal muscle inflammation, and a positive effect of the exer-
cise on the bones, are of a particular interest. For example,
inflammatory cytokines IL-6 and IL-7 are released as a result of
physical activity and ensuing muscle contraction; they are, how-
ever, activating bone resorption and turnover. On the contrary,
an over-secretion of interleukin-15 occurs due to resistance exer-
cise, and its beneficial effects involve a decrease in adiposity and
increase in bone mass (Quinn et al., 2009).
ROLE OF MUSCLES IN ENERGYMETABOLISM AND INSULIN
SENSITIVITY
The adipose tissue is an endocrine organ producing a variety of
factors which regulate energy metabolism and insulin sensitivity
(Sell et al., 2006). There are distict types of the adipose: white,
brown; subcutaneous, visceral, and inter/intramuscular tissue.
Adipose tissue protects other cell types from “lipotoxicity” by
providing a safe haven for surplus energy. On the other hand,
increased adipose tissue mass is associated with insulin resis-
tance, systemic dyslipidemia, hyperglycemia, hypertension, and
components of the metabolic syndrome (Dandona et al., 2005;
Despres, 2006). Lately, Schafer et al. (2010) found that fat infil-
tration of muscle was higher in adults with diabetes or impaired
glucose metabolism than in those with normal glucose levels (P <
0.001). Furthermore, fat infiltration of muscle was independently
associated with a 19% increased risk of incident clinical frac-
ture (hazard ratio = 1.19; 95% confidence interval = 1.04–1.36);
this association did not differ across glucose metabolism groups.
Skeletal muscle is a major depot responsible for glycogen syn-
thesis; therefore, there is an ongoing interest in the metabolic
interplay between adipocytes and skeletal myocytes. There are
suggestions of a negative crosstalk between body fat and skeletal
muscle, which results in disturbances of insulin signaling in skele-
tal muscle as well as insulin resistance (Sell et al., 2006). Direct
adipocyte–myocyte interaction was first explored by Dietze et al.
(2002), who demonstrated a direct cross-talk between human
adipocytes and myocytes in a co-culture model in which both
cell types shared the same medium. Co-culture with adipocytes
resulted in insulin resistance in skeletal muscle cells (Dietze et al.,
2002; Dietze-Schroeder et al., 2005). There is an effect of local fat
also on bone: using normal human osteoblasts co-cultured with
differentiating pre-adipocytes in vitro, Elbaz et al. showed that
inhibition of fatty acid biosynthesis prevents adipocyte lipotoxic-
ity on osteoblasts (Elbaz et al., 2010). After 3 weeks in co-culture,
osteoblasts showed significantly lower levels of differentiation and
function, with lower mineralization and expression of alkaline
phosphatase, osterix, osteocalcin, and Runt-related transcription
factor 2 (Runx2).
Evidence has been presented that adipose tissue communi-
cates with the rest of the body not only via free fatty acids
(FFAs) but also through adipose-derived cytokines (adipokines)
(Sell et al., 2006), which have been implicated in the impair-
ment of insulin sensitivity. On the contrary, adipokines leptin and
adiponectin have each been shown to increase fatty acid oxidation
and decrease in triglyceride storage in muscle, which may explain,
in part, the insulin-sensitizing effect of these cytokines (Dyck,
2009). Recently, Tenta et al. (2012) explored the relationship of
adiponectin with bone mass indices and bone metabolic markers
in middle-aged post-menopausal women without diabetes, and
showed significant associations with osteoprotegerin and IGF1
levels, suggesting an anabolic role of adiponectin. Together with
the co-culture experiments, these observations may contribute in
the understanding of the interplay between adipose tissue derived
hormones and bone metabolism (Tenta et al., 2012).
Koonen et al. (2010) provided insight into the mechanisms
by which aging becomes a risk factor for the development of
insulin resistance in middle-aged mice, demonstrating that lim-
iting skeletal muscle fatty acid transport is an effective approach
for delaying the development of age-associated insulin resistance
and metabolic disease during exposure to a high-fat diet. As
opposed to the high-fat diet, caloric restriction is frequently used
to improve function in aged animals. Thus, Selman et al. (2009)
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established that S6K1−/− mice live longer and show improved
health in later life than control mice. In these mice, the gene S6
Kinase 1 (S6K1) was inactivated. S6K1 is a ribosomal S6 kinase,
a component of the nutrient-responsive mammalian target of
rapamycin (mTOR) signaling pathway. Microarray data analysis
helped to characterize the gene-regulatory changes accompany-
ing the long-lived animals compared with wild-type mice. For
example, increased expression of genes associated with pathways
known to be associated with aging and with caloric restriction
(Ppargc1a, Ppara, Foxo1, Foxo3a, Pdk4, Glut1, Sirt1, and Ucp3),
was observed in the muscle of S6K1−/− mice. Down-regulation
of ribosomal S6 protein kinase signaling was reported to reg-
ulate mammalian lifespan supposedly by increasing activity of
AMP activated protein kinase (AMPK) (Selman et al., 2009), a
master regulator of cellular energy homeostasis (Hardie, 2007).
AMPK inhibits the mTOR pathway, an important regulator of
growth control and metabolism. Skeletal muscle mitochondrial
uncoupling activates AMPK (Gates et al., 2007; Neschen et al.,
2008), and in turn, AMPK has been shown to regulate energy
metabolism by modulating the activity of the histone/protein
deacetylase SIRT1 (Canto et al., 2009), a molecule supposed to be
involved in gene expression changes that mediate the increase in
longevity induced by caloric restriction (Ruderman et al., 2010).
PARACRINE AND ENDOCRINE CROSSTALK BETWEEN
MUSCLE AND ITS “NEIGHBORS”
There are several pathways with a plausible pleiotropic effect on
musculoskeletal system’s homeostasis, which seem to be among
major players in the aging of musculoskeleton.
GROWTH FACTORS
The contribution of growth factors to the muscle and other parts
of the system at different stages of development and aging, is well
documented. Growth hormone (GH) is an important regulator
of different physiological processes necessary for somatic growth
and development, starting with the differentiation of muscle and
bone cells, as well as metabolism of lipids and carbohydrates
(Perrini et al., 2010). GH regulation and signaling can occur
directly, through activation of specific GH receptors (Giustina
et al., 2008), or indirectly, through insulin-like growth factor 1
(IGF-1) (Laviola et al., 2007). IGF-1 is produced primarily by
the liver as an endocrine hormone in response to GH stimu-
lation (Ohlsson et al., 2009) or in target tissues in a paracrine
or autocrine fashion under the control of systemic hormones
(Laviola et al., 2007; Kapoor et al., 2008). It was shown that the
changes in GH and IGF-1 secretion that occur with aging are par-
alleled by a progressive loss of muscle mass and BMD (Bohannon,
1997). The contribution of IGF-1 to the maintenance of parts of
the musculoskeleton is well documented. Mechanical stimulation
of bone cells may induce elevated levels of IGF-1, which signals
the differentiation of osteoblasts into osteocytes (Schmid et al.,
1980); which maintain bone mass in response to normal load
(Bonewald and Johnson, 2008). IGF-1 levels are positively corre-
lated with muscle protein synthesis rates, specifically myofibrillar
protein (actin and myosin filaments) andMHC synthesis (Waters
et al., 2000). Overexpression of insulin-like growth factor and the
simultaneous loss of myostatin in muscle in vivo have been found
to have synergistic effects on myofiber growth and lessened fibro-
sis (Mann et al., 2011). The anabolic response to IGF-1, measured
as proteoglycan or collagen synthesis, declines in human articu-
lar chondrocytes from older donors with increasing age (Lotz and
Loeser, 2012).
Other growth factors regulating muscle mass include
mechano-growth factor, myostatin, vascular endothelial growth
factor (VEGF), or hepatocyte growth factor (HGF). In skeletal
muscle, at least two different IGF-1 isoforms are expressed due to
alternative splicing of the primary IGF-1 transcript (Goldspink,
2004). For the overview of growth factors and cytokines secreted
by muscle, as well as their potential effects on bone metabolism,
the reader is referred to a recent review by Hamrick (2011).
Mechano-growth factor (MGF) is a member of the IGF-1
superfamily that is induced in response to physical activity (Wu
et al., 2011). It has a marked ability to induce satellite cell
fusion for muscle repair and maintenance. Recent findings of up-
regulation of MGF in prostatic cancer cells might highlighted its
role also in cancer biology (Armakolas et al., 2010); this might
suggest that caution should be exercised for its therapeutic use
in older men (Thomis and Aerssens, 2012). Recently, Juffer et al.
(2012) investigated whether mechanical loading by pulsating fluid
flow modulates the messenger RNA (mRNA) and/or protein
levels of muscle anabolic andmetabolic factors in MLO-Y4 osteo-
cytes. They showed that loaded MLO-Y4 osteocytes differentially
express anabolic factors involved in the adaptive response of mus-
cle to mechanical loading (i.e., IGF-1, MGF, VEGF, and HGF).
Similarly to muscle fibers, mechanical loading enhanced expres-
sion levels of these growth factors in primary bone cells. The
authors concluded that osteocytes respond to mechanical load-
ing by producing more VEGF and HGF, which suggests that these
proteins previously played unrealized roles in bone remodeling
mediated by loading.
Fibroblast growth factor 2 (FGF2) is another polypeptide
growth factor that stimulates satellite cells (a.k.a. muscle pre-
cursor cells, MPCs). MPCs isolated from sarcopenic animals
exhibit a decreased proliferative response to FGF2 (Jump et al.,
2009). FGF2 is also a well-known osteogenic factor; it has pos-
itive effects on bone formation in estrogen-deficient rodents
(Hamrick, 2012).
TRANSFORMING GROWTH FACTOR-β (TGFβ) SUPERFAMILY,
MYOSTATIN, AND ACTIVIN RECEPTORS
TGFβ is a multifunctional protein that controls proliferation,
differentiation, and other functions in many cell types. In the
muscle, TGFβ seems to play an important role in aging-associated
fibrosis and muscle impairment. Overexpression of active Notch2
in C2C12 cells (the cell line established to become muscle) pre-
vents TGFβ from inducing the expression of collagen I, whereas
transient knockdown of Notch2 by siRNA in cultured myoblasts
results in the differentiation of C2C12 myoblasts into myofi-
broblastic cells that express fibrotic markers (Mann et al., 2011).
For the recent review on role of TGFβ in osteoblast differenti-
ation and bone formation, see Chen et al. (2012). The review
also highlights the different modes of cross-talk between TGF-
β/BMP and the signaling pathways of MAPK, Wnt, Hedgehog,
Notch, and FGFs in osteoblast differentiation and bone formation
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(Chen et al., 2012). The role of TGFβ in muscle fibrosis of aging
has been the subject of many studies [see review Dequeker
et al. (2003)]. Activated TGFβ induces fibroblasts to produce
type I collagen, fibronectin, and connective tissue growth fac-
tor (cTGF) and suppresses matrix metalloproteinases (MMPs).
Notably, MMP levels in uninjured muscle are generally low, but
secreted MMPs can degrade type IV collagen, fibronectin, proteo-
glycans, and laminin (Gillies and Lieber, 2011). When repeated
muscle injury occurs, elevated TGFβ continues to stimulate ECM
production and eventually leads to a fibrotic response (Gillies
and Lieber, 2011). Logically, TGFβ inhibitors can be used to
reduce aging-associated fibrosis in skeletal muscle (Mann et al.,
2011).
A lot of research in the last decade was focused on myo-
statin (growth differentiation factor 8, GDF8), a secreted TGFβ
protein family member that inhibits muscle differentiation and
growth. Myostatin is produced primarily in skeletal muscle cells,
circulates in the blood and acts on muscle tissue, by bind-
ing a cell-bound receptor called the activin type II receptor
[for the recent review, see Hamrick (2012)]. Thus, elevated lev-
els of myostatin expression are evident in disuse atrophy and
cachexia (of cancer and AIDS) (Hamrick, 2011). Contrarily,
inactivating mutations of the myostatin (MSTN, a.k.a. GDF8)
gene induce a hypermuscular phenotype in mammals, with pro-
nounced effect on bones (Hamrick et al., 2003). Importantly,
myostatin is released frommuscle during traumatic and catabolic
conditions that may inhibit and suppress bone repair. Lee
and McPherron (2001) previously showed that inhibition of
myostatin by genetic elimination using knockout mice or by
increasing the amount of the propeptide follistatin, resulted
in greatly increased muscle mass. Follistatin (also known as
activin-binding protein) is an autocrine glycoprotein that is
expressed in nearly all tissues of higher animals (Tortoriello
et al., 2001). Follistatin is known to regulate myostatin activ-
ity and muscle growth (Lee and McPherron, 2001). Kota et al.
(2009) showed that regulation of follistatin via gene therapy
also resulted in muscle growth and increases in strength in
non-human primates. The authors agreed with the findings in
mice detected by Lee and McPherron (2001), so the findings of
both studies point out that gene therapy may improve muscle
mass and function in patients with certain degenerative muscle
disorders.
Myostatin not only regulates the growth of muscle cells, but
also fibroblast activation and hence the progression of fibrosis in
the muscle. In the absence of myostatin, the improved regener-
ation and decreased fibrosis took place (Mann et al., 2011). It
appears that myostatin also regulates the structure and function
of tendon tissues, as the stiffness of tendons is 14 times higher in
myostatin-deficient mice than in the wild-type controls (Mendias
et al., 2008). Importantly, myostatin expression is increased by
glucocorticoids; this suggests that myostatin is required for the
catabolic effects of glucocorticoids, leading to muscle atrophy
(Gilson et al., 2007). It is well known that glucocorticoid-induced
enhanced proteolysis also corresponds to increase in bone loss
(Kanis et al., 2007).
Myostatin binds to the soluble activin type IIB receptor
(ACVR2B) and to a lesser extent to activin type IIA receptor
(ACVR2A), which act as myostatin antogonists and thus exert
differential anabolic activity in bone and muscle (Lee et al.,
2005). Digirolamo et al. presented data on muscles and bones
in three groups of mice given either one of two types of ACVR2
or placebo (Digirolamo et al., 2011). Their study findings sug-
gest that both ACVR2 and ACVR2B produce anabolic effects on
muscle and bone; however, ACVR2’s effect was greater on bone
than muscle, whereas ACVR2B’s effect was greater on muscle
than bone. The activin receptor types and their related func-
tion in the musculoskeletal system are summarized in Table 1.
In vitro and in vivo studies have demonstrated that both activin
A and its antagonist follistatin play opposite roles in bone forma-
tion (Eijken et al., 2007): follistatin increases bone formation in
mice, by inhibiting activin A in vivo using a decoy soluble activin
A receptor (Vallet et al., 2010). Activin A treatment can inhibit
mineralization in cultured osteoblasts. Loss-of-function of activin
type I receptor (ACVR1) in osteoblasts increases bone mass and
activates canonical Wnt signaling through suppression of Wnt
inhibitors sclerostin (SOST) and DKK1 (Kamiya et al., 2011).
Table 1 | Activin receptor types and their function in the musculoskeletal system.
Activin receptors/sub-units Function in bone/muscle References
ACTIVIN TYPE I RECEPTOR
ACVRA1 Essential for skeletal development.
Involved in ossification of muscles and joints in fibrodysplasia ossificans
progressiva (FOP) disease, through mutations in ACVR1 and noggin
gene.
A mutation causes endothelial cells to transform to mesenchymal stem
cells and then to bone
Chen et al., 2004; Lucotte et al., 2009; van
Dinther et al., 2010
ACVR1B Involved in muscle strengthening Windelinckx et al., 2011
ACVR1C Is used as an antagonist of myostatin, which inhibits muscle cells
proliferation
Digirolamo et al., 2011
ACTIVIN TYPE II RECEPTOR
AVCR2A Regulates muscle growth and bone formation Lee et al., 2005; Lotinun et al., 2010
AVCR2B Involved in the signaling pathway essential for initiating osteoblast
differentiation
Liu et al., 2012
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A point mutation in ACVR1 can cause fibrodysplasia ossificans
progressiva (FOP) in which ectopic ossification occurs in skele-
tal muscles and deep connective tissues (Lucotte et al., 2009; van
Dinther et al., 2010).
VITAMINS
The connection between muscle and bone can be regulated by
vitamins, most prominently, by vitamin D. Vitamin D, a key
regulator of bone metabolism, is also known to be significantly
associated with muscle strength: a lack of vitamin D, which is
associated with aging, can cause myopathy. In the elderly, vita-
min D deficiency is linked to muscle weakness, increased body
sway, and increased susceptibility to falls and fractures. Themech-
anisms underlying the effect of vitamin D on muscle strength are
not fully understood; thus, vitamin D action requires activation of
the vitamin D receptor, which is widely distributed in various tis-
sues including skeletal muscle (Endo et al., 2003; Grundberg et al.,
2004; Windelinckx et al., 2007). Gilsanz et al. demonstrated that
serum 25OHD was inversely related to the percent fat of skeletal
muscle, a relation that was independent of body mass or subcuta-
neous and visceral fat depots. Compared with women with nor-
mal serum 25OHD concentration, vitamin D-insufficient women
had approximately 24% greater muscle fat infiltration (but no
significant differences in the cross-sectional area of their thigh
muscles) (Gilsanz et al., 2010). Non-straightforward seems to
be the relationship between the serum levels of vitamin D and
osteoarthritis. Vitamin D has been shown to stimulate synthe-
sis of proteoglycan by mature articular cartilage in vitro, and
this suggests that vitamin D may directly affect articular cartilage
metabolism, but its relationships with the clinical OA seem to be
confounded by other aging-related processes.
Other vitamins are also have roles in the musculoskeleton reg-
ulation, however, less is known. Vitamin K deficiency has been
linked to a variety of age-associated conditions, including loss of
BMD or increased fracture risk, arterial calcification, and inflam-
mation (Shea et al., 2009). Bone-related conditions and arterial
calcification have been most widely studied in relation to vita-
min K availability (McCann and Ames, 2009), while there are
virtually no data on the vitamin K effect on skeletal muscle. On
the contrary, a role of Vitamin E in the muscle physiology seems
to be well known. Vitamin E could reduce muscle inflammation
(Tiidus and Houston, 1995). Since a large majority of vitamin E
is found in adipose tissue, this might reflect anti-oxidant proper-
ties of vitamin E and indicate its supplementation can help reduce
muscle damage caused by free radicals. Interestingly, mice with a
genetically-induced vitamin E deficiency, have high bone mass as
a result of a decrease in bone resorption. Vitamin E thus decreases
bone mass by stimulating osteoclast fusion according to Fujita
et al. (2012).
MENOPAUSE AND SARCOPENIA: IS THERE EVIDENCE FOR A
CAUSAL RELATIONSHIP?
Menopause is associated with a decline in estrogen levels, which
is translated into an increase in fat mass, as well as a decrease in
bone density, muscle mass, and muscle strength. Decline in mus-
cle mass (sarcopenia) is frequently observed in post-menopausal
women (Messier et al., 2011). During the menopausal transition,
there is a sharp fall in estrogen levels, therefore it has been sug-
gested that changes in female estrogen levels may play a role in
the development of sarcopenia duringmenopause. Estradiol (E2),
together with estriol (E3) and estrone (E1), belong to estrogens.
So far, there is limited evidence whether the loss of estradiol neg-
atively affects muscle mass and physical function. Ratiani et al.
(2012) were exploring lately the influence of estrogen on the
intensity of oxidative metabolism in women of reproductive and
menopausal age. For this study, two groups of women—less than
45 years old (reproductive age) and older than 45 (menopausal
age) were tested. It was found that the physiological reduc-
tion in estrogen levels during menopause by itself contributes
to impairment of oxidative metabolism and intensification of
inflammation, oxidative stress, hypoxia, and related conditions.
Aging is associated with a loss of sex hormone not only
in women but also in men; this phenomenon is called the
“andropause” or the “male menopause.” In men, reduction in the
levels of the androgen testosterone can trigger declines in mus-
cle mass, bone mass, and overall physical function (Horstman
et al., 2012). It was previously shown that administration of sup-
plemental testosterone orally to older relatively hypogonadal men
resulted in an increase in muscle mass and a decrease in body
fat (Wittert et al., 2003). Lately, the Toledo Study for Healthy
Aging (Carcaillon et al., 2012) found that there are sex differ-
ences in the association between serum levels of free testosterone
and frailty (a syndrome of aging-related loss and dysfunction of
skeletal muscle and bone) in an elderly population. The authors
suggested that although the age-associated decline in testosterone
occurs in both men and women, this decline does not arise to the
same extent in both sexes, suggesting a possible differential impact
on frailty according to sex.
Adverse effects of menopause on bones are well known
(Kanis, 1996); less obvious are effects of “andropause” on bones
(Ferrari et al., 2005). The uncertainties of the roles of major sex
hormones in muscle and in bones are illustrated in Figure 1.
Recently, a Finnish study investigated a link between the estrogen
replacement therapy (ERT) and skeletal muscle transcriptome
(Ronkainen et al., 2010). Long-term use of ERT was associated
with subtle differences in muscle transcript profiles and a better
muscle fiber composition, although no differences were observed
in mitochondrial DNA copy number or oxidative capacity per
muscle cross section. Similar to the menopausal etiology of osteo-
porosis, the role of estrogen has been a long-standing theme in
osteoarthritis research, since OA is more common in women than
in men (a ratio of ∼3:1). OA often begins around the time of
menopause, and incidence rises faster inmenopausal women than
in men of the same age. Joint pain is a common complaint at the
time of menopause or ERT withdrawal.
In addition to changes in androgen and estrogen levels,
another important player in the development of sarcopenia
in elderly population might be myostatin, a secreted TGFβ
family member that inhibits muscle differentiation and growth
(as detailed above). The relationship between testosterone and
myostatin in the humans is not fully understood, although
testosterone is known to reduce myostatin release in the mus-
cle (Kovacheva et al., 2010). Studies indicated that myostatin
release in the muscle is not necessary related to sarcopenia.
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FIGURE 1 | Possible changes in muscle and bone in response to sex hormone levels.
Ratkevicius et al. (2011) showed that serum concentrations
of myostatin and myostatin-interacting proteins do not differ
between young and sarcopenic elderly men. The authors sug-
gested that altered serum concentrations of myostatin-interacting
proteins might not contribute to sarcopenia with the possible
exception of follistatin-related gene (FLRG). FLRG encodes a
secreted glycoprotein that is highly homologous to follistatin and
binds activins and bone morphogenetic proteins (Wang et al.,
2003). In a different study, in young and old men treated with
graded doses of testosterone, myostatin levels were significantly
higher on day 56 than on baseline in both young and older men.
Notably, changes in myostatin levels were significantly correlated
with changes in total and free testosterone only in young men,
probably suggesting that response to testosterone is affected by
age (Lakshman et al., 2009).
GENETICS OF SARCOPENIA AND OTHER COMMON
MUSCULOSKELETAL AGE-RELATED CONDITIONS:
EVIDENCE OF PLEIOTROPY?
RELATIONSHIP BETWEENMUSCLE AND BONE MASS IN ADULTS
Skeletal muscle has a close functional relationship with bone,
starting in embryonic period. Developmentally, osteoblasts and
muscle cells derive from a common mesenchymal precursor, the
pluripotent mesenchymal stem cells. For example, the C2C12 cell
line is established to become muscle but can be induced to dif-
ferentiate into osteoblasts in the presence of BMP-2 (Darcy et al.,
2012).
Studies of both humans (adults and children) and labora-
tory animals have documented a strong, positive correlation
between muscle strength and bone mass (Gilsanz et al., 2006).
Developmentally, this process is a reflection of allometry (usu-
ally defined as the covariance between the form, shape, and size
of body part and size of the whole organism) (Karasik and Kiel,
2010). Further in the life, muscle atrophy is concomitant with
the observed bone loss (Judex et al., 2004). There is a “biome-
chanical” explanation for this phenomenon. Mechanical loads
activate new bone formation on cortical and trabecular surfaces;
strain can activate some bone cells, which then respond with gene
activation, increased metabolism, growth factor production, and
building the matrix (Forwood, 2001; Frost, 2003). For example,
in their recent study, Zhang et al. (2012) found that osteogenic
response of bone mesenchymal stem cells to continuous mechan-
ical strain is dependent on the signaling of extracellular regulated
protein kinase (ERK) 1/2 and Runx2. Runx2 is a key transcription
factor known to regulate the differentiation and/or function of
osteoblasts. It is also an important mediator of the ability of
metastatic breast cancer cells to directly modulate both osteo-
clast and osteoblast function. Sears et al. (2007) showed there is
an evolutionary association between Runx2 repeats (changes in
glutamine-alanine tandem-repeat ratio) and facial skull length in
carnivores suggesting Runx2 tandem repeats providing a flexible
genetic mechanism to rapidly changing the timing of ossification.
Facial length is co-regulated with mastication, which is a product
of muscle forces. Changes in bone length thus probably reflect a
co-evolution of muscles and bones and suggest a pleiotropic role
for Runx2 in mammalian evolution (Sears et al., 2007).
Furthermore, muscle strains are needed for fracture repairs.
According to Hao et al. (2012), bony union was affected in rats
whose quadriceps were treated with botulinum toxin-A (BXTA);
saline was injected into the contralateral quadriceps. At different
time points up to 8 weeks post-fracture, a gap was still visible on
X-ray images of that side and nomature osseous calluses or woven
bone were found by histology on the BXTA-treated side. Finally,
biomechanical testing indicated that the femora of the BXTA-
treated side exhibited inferior mechanical properties compared
with the control side.
Beyond an obvious biomechanical importance of muscle
strains for fracture repair, locally-released factors seem playing a
role: covering bone fractures with muscle hastened healing and
resulted in an increase in union strength. Thus, muscle-derived
stromal cells exposed to an adjacent fracture differentiate into
osteoblasts in vitro; the osteogenic potential of these cells exceeds
that of adipose and skin-derived stromal cells and is equivalent
to bone marrow stromal cells. The recruitment and differentia-
tion of muscle-derived stromal cells in response to tumor necrosis
factor-α (TNF-α) was shown to promote an accelerated heal-
ing of the fracture in an in vivo murine model (Glass et al.,
2011). A local injection of recombinant human TNF-α on the
first two days after fracture-inducing surgery accelerated heal-
ing of the fracture. By day 28, TNF-α treated animals showed
significantly higher callus mineralization compared to controls.
Importantly, TNF-α is one member of a large family of inflam-
matory cytokines that share common signal pathways, including
activation of the transcription factor Nf-κB. NF-κB is a key reg-
ulator of inflammation in skeletal muscle (Peake et al., 2010),
thus plays a critical role in muscle atrophy. As a skeletal catabolic
agent, TNF-α stimulates osteoclastogenesis while simultaneously
inhibiting osteoblast function (Nanes, 2003). Paradoxical role of
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TNF-α in fracture repair is interesting, since it probably points
out at a necessity of resorption of bone edges and the regulated
apoptosis in the callus for its ossification, osteon integrity, and
thus an efficient fracture healing.
Both bone and muscle show major changes during aging and
in the same direction, with sarcopenia and osteoporosis con-
tributing to frailty (Matthews et al., 2011). Similarly to bone,
muscle tissue deteriorates with the age. Sarcopenia term has been
coined which is based on lower muscle quality, just as osteoporo-
sis is typified by both decreased bonemass and structural integrity
(Matthews et al., 2011). In addition, based on the mechanostat
theory, the muscle-bone unit has been defined as a functional sys-
tem whose components are under the common control of several
hormones (Zofkova, 2008). Sex steroids modulate the function of
the muscle-bone unit in adulthood and aging. Therefore, based
on theoretical principles of allometry and the ample empirical
data on co-regulation (provided above), the existence of genes
determining characteristics of both traits is plausible (Karasik and
Kiel, 2010).
GENETIC CORRELATION BETWEEN THE MUSCLES AND BONES
AND QUANTITATIVE TRAIT LOCI AFFECTING BOTH
Evidence for genetic correlations was described in the literature
between geometric parameters of femoral bone neck and total
body lean mass in men and women (Sun et al., 2006). It is not
surprising, since lean mass was positively associated with section
modulus and cross-sectional area in both sexes (r = 0.36–0.55,
p < 0.05) (Moseley et al., 2011). Deng et al. (2007) performed
a bivariate genome linkage analysis which produced two chro-
mosomal regions, 5q35 and 10q24, with pleiotropic effects on
these phenotypes. Results in the FraminghamOsteoporosis Study
demonstrated similar bivariate genetic correlations between leg
lean mass and cross-sectional femoral geometry; bivariate linkage
analysis identified significant quantitative trait loci (QTL) of leg
lean mass shared with shaft CSA on chromosome 12p12–12p13
and with neck shaft angle, on 14q21–22 (Karasik et al., 2009).
One cannot exclude that a third trait (such as fat mass) might be
involved in pleiotropic relationships between bone and muscle,
probably even as a mediator of their relationship.
There is an importance studying complex diseases and aging
related processes through large animal models and translate ani-
mal research findings to future biomedical sciences. As of now,
mostly small organisms are being used for this purpose, for exam-
ple, zebra fish are being explored as a model for investigating the
effect of aging onmale reproduction (Kanuga et al., 2011). In live-
stock, we only find genetic evidence for skeletal muscle mutations
which affect muscle growth and development but the effect on
aging is not yet being explored. In sheep for example, the callipyge
(CLPG) mutation causes post-natal muscle hypertrophy, which
is localized in the pelvic limbs and loin (Cockett et al., 2005).
Muscles from CLPG-expressing lambs enlarge to different degree
and not all muscles are affected (Cockett et al., 2005). The CLPG
trait in sheep exhibits a novel mode of inheritance termed “polar
over-dominance” while the only animals that express the CLPG
phenotypes are those heterozygotes who inherited the CLPG
mutation from their sire (Georges et al., 2003). Enhanced skele-
tal muscle growth is also observed in animals with the Carewell
(or rib-eye muscling) mutation, and a double-muscling pheno-
type has been documented for animals of the Texel sheep breed
(Cockett et al., 2005). QTL were identified for traits related to
bony carcass and meat quality in sheep while genome-wide sig-
nificant QTLs were mapped for muscle (Karamichou et al., 2006)
and bone (Campbell et al., 2003) densities. Since clinical stud-
ies are not easy to be implemented, large animals can be used as
models to explore aging-related complex diseases and their effect
on the musculoskeletal system. Future identification of the actual
genes or mutations responsible for these bone and muscle related
QTLs in livestock and especially their role in aging, will increase
the understanding of vertebrate musculoskeletal biology.
PLEOTROPIC RELATIONSHIPS BETWEEN BONE ANDMUSCLE:
IS THIS A “TRUE” PLEIOTROPY OR A MEDIATION?
There are several potential mechanisms underlying associations
between genetic variants and the parts of the musculoskeletal
apparatus, including the mediation of environmental influences
by genetic factors (Karasik, 2011). It was previously postulated
that the spectrum of pleiotropic effects of a gene on a mor-
phological trait may include direct or indirect effect with a
possible continuum in-between (Kelly et al., 2006). We previ-
ously mentioned two possible scenarios of gene actions. The first
one includes pleiotropic effects of gene polymorphisms on two
traits, Trait1 and Trait2 (say, muscle and bone), and the sec-
ond includes a conditional model (mediation), in which a gene
is associated with one trait, and that trait in turn influences or
affects another trait. (see scheme in Figure 2, scenarios A and B).
Additional possible scenario can be suggested where a gene is
affecting a third—unknown—trait (Trait3), which in turn affects
directly both muscle and bone (confounding). In any case, prod-
ucts of the same gene(s) can be used as biomarkers for two traits
simultaneously.
An example for cumbersome relationships when pleitropy is
suspected, comes from a naturally occurring recessive mutation,
named “mini muscle” (MM), that causes some 50% reduction
in hind limb muscle mass of mice (Kelly et al., 2006). Observed
reduction of both muscle mass and bone structure could rep-
resent direct pleiotropic effects of the MM allele if the gene
is expressed in the stem cell populations early in development.
Alternatively, the gene might act intrinsically only on the muscle
cells and not the bone cells, and the MM bone phenotype could
arise via weaker mechanical input from the reduced hind limb
musculature (Wallace et al., 2012).
Pleiotropy in humans is ubiquitous (Sivakumaran et al., 2011);
there are multiple examples in the literature, starting with a text-
book example of phenylketonuria (PKU), caused by a deficiency
of the enzyme phenylalanine hydroxylase, which is necessary
to convert the essential amino acid phenylalanine to tyrosine.
A defect in the single gene that codes for this enzyme there-
fore results in the multiple phenotypes associated with PKU,
including mental retardation, eczema, and pigment defects that
make affected individuals lighter skinned (Paul, 2000). In the
most recent study, a single nucleotide polymorphism (SNP)
rs11655470 in the region where the CRHR1-MAPT genes are
located was related to infant head circumference (Taal et al.,
2012). Variants in or nearCRHR1 have been previously associated
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FIGURE 2 | Diagram of three possible scenarios (A, B, and C) for
pleiotropic bone-muscle interactions (T = trait).
with brain development and BMD (Rivadeneira et al., 2009).
In a parallel paper, Ikram et al. (2012) showed that a correlated
SNP in the same region (rs9303525; linkage disequilibrium, LD,
r2 = 0.22 with rs11655470) is associated with adult intracranial
volume. Since LD between the variants found to be low, it is
possible that they represent separate, independent signals. After
a series of statistical models with adjustments of one trait for
the other, the investigators concurred that these signals reflect a
third marker influencing both phenotypes, the head circumfer-
ence and intracranial volume. In the above example of the MM
allele, the authors similarly rise a possibility that there exists a cir-
culating hormone or growth factor that regulates bothmuscle and
bone development (Wallace et al., 2012). As occurs when the con-
founded scenario is a correct one, frequently there is a third SNP
which seems to be associated with both traits, whose relationship
with a combination of traits is stronger than with either trait. The
biological causality underlying the potentially-pleiotropic associ-
ations is largely unknown, and cannot be resolved with statistical
means; the definite answer should come from the “bench”—
functional studies.
USING GENOMIC TOOLS IN ORDER TO DETECT GENETIC
VARIANTS INVOLVED IN PLEIOTROPIC MECHANISMS
Recently, in parallel with the upsurge of the whole-genomic
genotyping and sequencing techniques, large-scale analyses and
data mining methods have been developed to identify associ-
ations at a genomic level. These high-throughput techniques
have enabled genome-wide association studies (GWAS), in which
about 100,000—1,000,000 SNPs (representative of millions of
SNPs in human genome) are tested. Linkage studies, GWAS and
re-sequencing as well as new bioinformatic tools pointed out
some interesting musculoskeletal genes, whose, in turn, con-
tribute to identifying new pathways of possible pleiotropic value.
We summarized the candidate genes with plausible biological
pleiotropic effects on muscles and bones, as well as other tissues,
in Table 2. For example, a possible candidate for pleotropic effect
between bone and muscle is α-actinin 3 (ACTN3) gene which is
highly expressed in fast skeletal muscle fibers (Yang et al., 2011).
ACTN3 is one of the two isoforms of α actinin which are found
in Z-discs of skeletal muscle (Chan et al., 2008; Yang et al., 2011).
Genetic studies previously suggested that the absence of ACTN3
is detrimental to sprint and power performances in elite athletes
and in the general population (Chan et al., 2008; MacArthur et al.,
2008). Yang et al. (2011) recently showed that ACTN3 deficiency
is associated with reduced bone mass in humans and mice.
As follows from the Table, along with the biological candidates,
some genetic studies produce “serendipitous” pleiotropic find-
ings. Similarly, genetic association studies for rare diseases have
their merit by uncovering some facets of the complex muscu-
loskeletal biology. Often methodologically different, both belong
to the domain of human genetic study. Here are examples of
recent discoveries of genes with a potentially-pleiotropic role in
the musculoskeleton.
In a large GWAS performed by the GEFOS consortium, a
locus at 5q14—near myocyte enhancer factor 2C (MEF2C)—
was found to be significantly associated with BMD related traits
(Rivadeneira et al., 2009). Besides being involved in myogenesis
(Cesana et al., 2011) like the other myogenic basic helix-loop-
helix proteins, members of MEF2 family of regulatory proteins
are participating in bone-relevant pathways including endochon-
dral ossification (Kramer et al., 2012). Notably, by virtue of being
widely pleiotropic, MEF2C was associated with different traits,
such as platelet count, retinal vascular caliber, tonometry, and
adult height. Future research should be performed to decipher a
“real” musculoskeletal pleiotropy of this molecule, as opposed to
a mediation effect via some primary basic mechanism active early
in development.
Another segue, now into the pathobiology of tendons, was pro-
vided by a recent GWAS of Dupuytren contractures (Dolmans
et al., 2011). Dupuytren’s disease is a fibromatosis of the flex-
ors, whose prevalence increases with age and leads to flexion
contractures affecting fingers. Six of the 9 loci identified by
the study included genes known to be involved in the Wnt-
signaling pathway, including WNT4, WNT2, WNT7B, SFRP4,
SULF1, and RSPO2. The latter gene encodes R-spondin, a mem-
ber of the family interacting with frizzled receptors and LRP5/6
to induce β-catenin signaling; Rspo2 expression is required for
Wnt11-mediated osteoblast maturation. Wnt-signaling pathway
is among the leading regulators of bone mass, as is shown time
and again (Rivadeneira et al., 2009; Zhang et al., 2010; Estrada
et al., 2012). In muscle, a conversion of myogenic into fibro-
genic lineages could be abrogated experimentally by treating
mice with Wnt inhibitors (Mann et al., 2011). Similarly, injec-
tion of the Wnt antagonist DKK1 into the skeletal muscles of
mdxmice (see below) significantly reduced fibrosis. Indeed, there
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was reduced fibrosis and enhanced muscle regeneration in aged
muscle injected with DKK1, whereas no change was observed
in young similarly treated muscle (Brack et al., 2007). A mech-
anism of Wnt-induced cell-fate changes from myogenic to non-
myogenic cells in resting satellite cells awaits further validation
(Mann et al., 2011). Notably, a role of another important Wnt
antagonist, SOST in skeletal muscle has not been explored yet.
Other evidence for the importance of muscle-to-bone cross-
talk in bone health and disease comes from the rare diseases
of muscles. Thus, DMD is an X-linked disease where the gene
encoding the protein dystrophin is affected by various mutations.
Fractures are a significant problem in patients with DMD (young
boys). Two recent studies investigated bones affected by the defi-
ciency of dystrophin, which is mutated in DMD. Both used
dystrophin-deficient mdx mice, a model of human DMD. Thus,
one study (Novotny et al., 2011) showed that tibiae of mdx mice
had up to 50% lower strength and stiffness compared to wild-
type mice; they had reductions in cortical cross-sectional moment
of inertia, cross-sectional area, and in trabecular bone volume.
Importantly, this compromised bone strength was already obvi-
ous in very youngmice (Novotny et al., 2011), which corresponds
to poor bone health in DMD boys. The second group (Nakagaki
et al., 2011) investigated the changes that occur in the femur of
young mdx mice, at 21 days of age. They also demonstrated a
lower strength, stiffness and energy absorption capacity in mdx
femora, which were shorter, had a smaller cortical area and thick-
ness, and manifested changes in the ECM and collagen organiza-
tion. Interestingly, at 3 weeks of age the muscle damage in mice
was still not significant, thus it is a lack of DMD expression, even
in the absence of significant muscle fiber degeneration, which
seems to be affecting bones (Nakagaki et al., 2011). The underly-
ing molecular mechanisms for the effects on bone, whether direct
or indirect, have not yet been elucidated in detail, which makes
this exploration tantalizing. The above—semi-serendipitous—
findings of pleiotropy, call out for a systematic study dedicated to
identifying genetic variants underlying muscle and other related
traits, for shared genetic mechanisms underlying parts of the
musculoskeleton. In the next sub-section we discuss a framework
that may be useful in analyses of the “-omics” data.
POST-GWAS AND GENE EXPRESSION STUDIES
Our knowledge of the genetic architecture of common mus-
culoskeletal diseases remains rudimentary, in part due to the
complex relationship between the phenotype and genotype (and
the environmental effects). Only recently has it been possible to
address the need for high throughput gene expression studies
(RNA-seq, transcriptome) focusing on multiple relevant tissues,
such as differential expression of skeletal andmuscular genes with
aging. Transcriptional profiles of many human tissues, including
muscle (Welle et al., 2004; Zahn et al., 2006; Wallace et al., 2012),
skin (Lener et al., 2006), tendons (Jones et al., 2006), and cartilage
(Swingler et al., 2009); have been generated; however, for human
bones, there are fewer available resources (Grundberg et al., 2008;
Reppe et al., 2010).
Mantila Roosa et al. (2011) study used the rat forelimb load-
ing model to evaluate the extent of alternative splicing in bone
under mechanical loading. Animals were subjected to loading
sessions every day, and ulnae were sampled at 11 time points,
from 4 h to 32 days since loading started. They identified multi-
ple alternatively spliced genes encoding cytokines, ion channels,
solute carriers, and notably, muscle-related genes. Previously,
Paic et al. (2009) isolated osteocyte and osteoblast cell popula-
tions for microarray analysis. Multiple muscle-related genes were
downregulated in osteoblasts with respect to osteocytes, includ-
ing many of the same genes downregulated by loading in the
study of Mantila Roosa et al. (2011). Although the involvement
of muscle-related genes and proteins in bone biology is not well
understood, it is clear that they are highly regulated in bone cells.
One can speculate that finding of the muscle-related genes being
downregulated both during bone formation and in osteoblasts
compared to osteocytes is linked to mechanosensitivity, which is
characteristic of osteocytes.
Transcription factors that play a role in ossification during
development are expected to participate in post-natal fracture
repair since the endochondral bone formation that occurs in
embryos is recapitulated during fracture repair (Reumann et al.,
2011). The knowledge of their interplay during the bone forma-
tion, as well as functioning as parts of muscle-bone unit, should
provide the strategic basis for interventions aimed at improv-
ing tissue repair after fracture, by mechanical stimuli or some
humoral factors, or by a combination of both.
Several studies have used gene profiling to identify gene clus-
ters and individual genes in muscle that change with age (Roth
et al., 2002; Giresi et al., 2005; Dennis et al., 2008, 2009; Thalacker-
Mercer et al., 2010). Furthermore, expression profiling was used
to identify genes expressed in adult rat and human tendon tissue
(Jelinsky et al., 2010). Using this technique, approximately 1,600
transcripts appeared to be selectively expressed in rat tendon tis-
sue and approximately 300 transcripts appeared to be selectively
expressed in human tendon tissue, with ∼20 genes overlapping
between both human and rat tendon tissue. Of these com-
mon tendon-selective genes, thrombospondin-4 and tenomod-
ulin were found to have the highest tendon-selective expression
compared to other tissues examined. Interestingly, expression of
these tendon-selective genes, which are present in primary tendon
fibroblasts, is lost when these cells are placed in two-dimensional
culture systems (possibly suggesting that mechanoception is a
factor for expression of these genes). Identification of tendon-
selective genes provides potential molecular tools to facilitate a
better understanding of tendon development and repair.
Drummond et al. (2011) profiled microRNA (miRNA) expres-
sion patterns in aging human skeletal muscle followed by in-
depth functional and network analysis. In a classical fashion
of such experiments, muscle biopsy samples from 19 younger
men (age 31 ± 2) were compared with the older (73 ± 3 yrs
old; n = 17). Eighteen miRNAs were differentially expressed,
including Let-7 miRNA family members, Let-7b and Let-7e
(Drummond et al., 2011). A higher expression of Let-7 family
members that may down-regulate genes related to cellular prolif-
eration fits well into our understanding that older human muscle
is characterized by reduced muscle cell renewal and regeneration.
Expression QTLs (eQTLs) can be used as a tool assessing
genetic regulation of the expression levels of mRNA in desired
tissues. These eQTLs can be mapped to a variant in a local
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gene (cis eQTLs) or to variant on a different chromosome (trans
QTLs). In porcine, identification of eQTLs of genes expressed in
longissimus dorsi found to be associated with meat quality traits
(Ponsuksili et al., 2010). As an example for the adipose tissue,
Small et al. (2011) and the MuTHER consortium demonstrated
that the Type 2 diabetes andHDL-cholesterol associated cis-acting
eQTL of the maternally-expressed transcription factor KLF14 acts
as a master trans-regulator of adipose gene expression. Expression
levels of genes regulated by this trans-eQTL are highly-correlated
with concurrently-measured metabolic traits, and a subset of the
trans-genes harbor variants directly associated with metabolic
phenotypes. The authors suggested that by leveraging “-omics”
data from multiple sources they are able to discover new biologi-
cal and functional insights. A note of caution should be sounded
while interpreting these experiments, since the cell culture and
animal models may not reflect the complex dynamic interactions
between genes and the environment that form the basis of human
phenotype (Franceschi et al., 2007).
CONCLUSION
The pathobiology of many of the musculoskeletal diseases
remains obscure, as do factors affecting disease severity (Laing,
2012). Thus, for example, the establishment of new therapies,
such as regenerative medicines, for injured tendons has been
delayed by a limited understanding of tendon biology (Ito et al.,
2010). Several markers have been shown to correlate with the
burden of musculoskeletal diseases; additionally new techniques
must be developed to identify and quantify the biomarkers in
order to support both genetic diagnostics and a genetic study,
which is a powerful tool in biological discovery. We need to
focus on genetic aspects of the cross-talk between muscle and
its “neighboring” tissues, to find previously unknown pathways
of inter-compartmental communication. Multivariate methods
for large-scale data analysis and mining of results were proposed
and validated (Shriner, 2012). Ideally, a multivariate GWAS,
identifying genetic variants underlying both bone and muscle,
should be replicated in large human cohorts. Similarly, tantaliz-
ing findings of pleiotropy between the genes regulating muscle
and energy metabolism, insulin resistance, fat depots, and repro-
ductive aging, should be explored further.
Several studies have been proposed in this Perspective that
could address the areas of immediate interest, and the key ques-
tions can be summarized as follows. Focus should be on a pos-
sibility that growth factors (inflammatory cytokines, myokines,
etc.) expressed in muscle could affect signaling in bone cells. New
methods are needed to accurately measure the in vivo mechani-
cal responses and in particular, how aging may affect the ability
of mechanical loading to stimulate muscles by activating satellite
cells (Thomis and Aerssens, 2012) and further trigger anabolic
responses in bones (Wu et al., 2011). Therapeutic applications
of the biological knowledge of muscle-bone-cartilage interface
can further be extended to the fractures: risk prevention by soft-
tissue cushion, fracture repair by adjacent muscles, or improving
tendon-bone attachment in orthopedics. This knowledge would
help institute treatment interventions aimed at improving bone
tissue repair and successful regeneration of healthy muscle, thus
reducing adverse outcomes in vulnerable populations, such as
aged people and others (e.g., professional athletes). Combined
strategies will be crucial to ameliorate muscle loss with the
ensuing inflammation, fatty infiltration, and fibrosis, including
systemic delivery of anti-inflammatory or anti-aging agents and
gene-corrected cells, adapted for the local milieu (Mann et al.,
2011). More fundamental study is desired to learn how aging
contributes to musculoskeletal diseases. Answers to these ques-
tions will vastly improve our understanding of normal function of
the musculoskeleton as a whole. Finally, identifying mechanisms
by which etiologies of several diseases are interconnected, will
provide potential targets for systemic therapeutic interventions.
From a general gerontological perspective, a rapidly aging sys-
tem such as the musculoskeletal provides challenges for studying
its normal decline and trying to prevent it but also forthcoming
rewards if our efforts succeed.
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